Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cannabis Bioscience International Holdings (CBIH) Enterprise Value (2022 - 2026)

Cannabis Bioscience International Holdings filings provide 5 years of Enterprise Value readings, the most recent being -$90.0 for Q1 2026.

  • On a quarterly basis, Enterprise Value rose 83.58% to -$90.0 in Q1 2026 year-over-year; TTM through Feb 2026 was -$90.0, a 83.58% increase, with the full-year FY2025 number at -$12952.0, down 1615.5% from a year prior.
  • Enterprise Value reached -$90.0 in Q1 2026 per CBIH's latest filing, up from -$132.0 in the prior quarter.
  • The five-year high for Enterprise Value was -$90.0 in Q1 2026, with the low at -$25655.0 in Q1 2023.
  • A 5-year average of -$5800.4 and a median of -$881.5 in 2024 define the central range for Enterprise Value.
  • Year-over-year, Enterprise Value soared 98.6% in 2023 and then plummeted 1615.5% in 2025.
  • Year by year, Enterprise Value stood at -$24089.0 in 2022, then soared by 98.6% to -$337.0 in 2023, then plummeted by 197.33% to -$1002.0 in 2024, then surged by 86.83% to -$132.0 in 2025, then skyrocketed by 31.82% to -$90.0 in 2026.
  • Per Business Quant, the three most recent readings for CBIH's Enterprise Value are -$90.0 (Q1 2026), -$132.0 (Q4 2025), and -$223.0 (Q3 2025).